HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inverness Forced To Release Pregnancy Test Technology

This article was originally published in The Tan Sheet

Executive Summary

Inverness Medical Innovations must clear a path for the introduction of a water-soluble dye technology for consumer pregnancy tests under a settlement with the Federal Trade Commission

You may also be interested in...



FTC Staffing Up To Boost Consumer Health Fraud Enforcement

The Federal Trade Commission plans to add staff focused on enforcement against fraudulent dietary supplement claims in fiscal 2011

FTC competition head departs

David Wales leaves in May after nine months as acting director of the Federal Trade Commission's Bureau of Competition, the agency says in an April 2 statement. Wales joined FTC in April 2006 as deputy director of the bureau and oversaw cases including the settlement of the Whole Foods and Wild Oats Markets merger, and Inverness Medical Innovations' alleged anticompetitive purchase of a pregnancy test technology (1"The Tan Sheet" Dec. 1, 2008, In Brief and 2"The Tan Sheet" Jan. 5, 2009, p. 14)

Sales & Earnings In Brief

Inverness JV results: The first product from Inverness Medical Innovations' consumer diagnostic joint-venture with Procter & Gamble is expected to launch in the U.S. late this year following an international launch, Inverness announces during its fiscal 2007 fourth-quarter earnings call Feb. 20. In May 2007 the firms completed a joint venture to create SPD Swiss Precision Diagnostics, a business that develops, manufactures and markets diagnostic products including pregnancy tests and fertility/ovulation monitoring products (1"The Tan Sheet" Jan. 1, 2007, p. 10). During the October-December period, responsibility for U.S. sales and distribution of SPD's products was transitioned from Inverness to P&G. Inverness' consumer diagnostics business achieved sales of $29.7 million in the quarter, compared to $42.2 million in the prior-year quarter as the firm incurred $16.1 million in costs linked to the joint venture...

Related Content

Topics

UsernamePublicRestriction

Register

RS136562

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel